[3H]‐L‐2‐amino‐4‐phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a
- 1 December 1995
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 116 (8) , 3279-3287
- https://doi.org/10.1111/j.1476-5381.1995.tb15136.x
Abstract
1. The ligand binding site of subtype mGluR4a of the metabotropic glutamate receptor family was characterized by using [3H]-L-2-amino-4-phosphonobutyrate ([3H]-L-AP4) binding. 2. Specific [3H]-L-AP4 binding to membranes prepared from baby hamster kidney (BHK) cells transfected with a vector encoding mGluR4a accounted for 60-70% of the total binding whereas no specific binding of [3H]-L-AP4 was observed to membranes prepared from BHK cells expressing the vector only. 3. Specific binding of [3H]-L-AP4 to mGluR4a was detectable at 0 degree C, was saturated with 10 min and enhanced by Cl(-)-ions but not by divalent cations (Mg2+, Ca2+, Mn2+). 4. [3H]-L-AP4 binding showed a maximal binding density (Bmax) of 3.0 +/- 0.5 pmol mg-1 protein and an affinity (KD) of 441 nM. A modest decrease in affinity was observed in the presence of 0.1 mM guanosine-5'-O-(3-thio)trisphosphate-gamma-S, the KD being 761 nM and the Bmax 3.4 +/- 0.6 pmol mg-1 protein. 5. The following rank order of affinity for mGluR4a was observed: L-AP4 = L-serine-O-phosphate > glutamate = (2S,1S,2S)-2-(carboxycyclopropyl)-glycine > 1-amino-3-(phosphonomethylene)cyclobitanecar-boxylate > > (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate = quisqualate > ibotenate. 6. A highly significant correlation was observed between the potencies of the compounds to inhibit forskolin-stimulated cyclic AMP-formation in BHK cells expressing mGluR4a and the affinity for displacement of [3H]-L-AP4 binding from mGluR4a suggesting that this binding site is functionally relevant. 7. In conclusion, [3H]-L-AP4 is a suitable radioligand for characterizing mGluR4a when expressed in BHK cells. Interestingly, a significant correlation was found between the ability of various compounds to displace [3H]-L-AP4 binding from mGluR4a and the previously observed potencies for inhibition of synaptic transmission via L-AP4 sensitive glutamatergic pathways. These data support the hypothesis that the L-AP4 receptor is contained within the mGluR family.Keywords
This publication has 45 references indexed in Scilit:
- Effects of bromohomoibotenate on metabotropic glutamate receptorsNeuroReport, 1994
- Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor familyEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Antioxidant protection of Bio-normalizer in cerebral ischaemia-reperfusion injury in the gerbilNeuroReport, 1993
- Partial agonists, full agonists, antagonists: dilemmas of definitionTrends in Pharmacological Sciences, 1993
- L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type iv metabotropic glutamate receptor which is negatively coupled to adenylate cyclaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Stimulation intensity as critical determinant of presynaptic receptor effectivenessTrends in Pharmacological Sciences, 1990
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- dl-2-[3,4-3H]Amino-4-phosphonobutyrate binding sites in the rat hippocampus: distribution and possible physiological roleBrain Research, 1987
- Characteristics of chloride-dependent incorporation of glutamate into brain membranes argue against a receptor binding siteNeuropharmacology, 1987
- The Ca2+/Cl− dependent L‐[3H]glutamate binding: a new receptor or a particular transport process?FEBS Letters, 1984